For synthesis of 30 grams of the target compound, task order period of performance: 2/28/2018-4/27/2018

Ended Awarded Feb 28, 2018 Last action Jan 8, 2020

Contract number: HHSN26100003
Awardee: Alchem Laboratories Corporation UEI LD2KY6H7KMQ5
Awarding agency: National Cancer Institute National Institutes of Health, Department of Health and Human Services
Obligated: $54,579

Award facts

Opportunity: N02CM7700018 Solicitation number

Synthesis of Non-GMP Small Molecules Award Notice · Posted Sep 14, 2017

Synthesis of Non-GMP Small Molecules Award Notice · Posted Nov 23, 2016
Contract value 100% obligated: $54,578.89 Current and potential, with all options
Completion date 100% complete: May 25, 2018 Current and potential, with all options
NAICS code: 325412 Pharmaceutical Preparation Manufacturing
PSC: B599 Special Studies/Analysis- Other
Set-aside: No set-aside
Competition: Full and Open Competition after exclusion of sources Negotiated Proposal / Quote
Pricing: Cost Plus Fixed Fee
Place of performance: Santa Fe, FL 32615, USA

Award details come from SAM.gov/FPDS.

Action	Obligated	Date
Close Out P00003 · Synthesis of 30 grams of the target compound, task order HHSN26100003. To period of performance: 2/28/2018-5/25/2018	-$57	Jan 8, 2020
Supplemental Agreement for work within scope P00002	$0	May 18, 2018
Supplemental Agreement for work within scope P00001 · For synthesis of 30 grams of the target compound, task order HHSN26100003. To period of performance: 2/28/2018-5/18/2018	$9,720	Apr 27, 2018
Original award	$44,916	Feb 28, 2018

HHSN26100003 was awarded to Alchem Laboratories Corporation by National Cancer Institute (National Institutes of Health) on February 28, 2018.

The government has obligated $54,579 on HHSN26100003.

Yes. HHSN26100003 is a delivery order under HHSN261201700007I, an indefinite delivery contract.

The extent of competition for HHSN26100003 was full and open competition after exclusion of sources.

On GovTribe

Try for free Login